Search Results (2,751)

Polyoxometalates (POMs) are anionic metal oxide nanoclusters with rich redox chemistry, making them promising candidates for photocatalysis. However, their strong UV-light absorption and rapid charge recombination hinder visible-light applications. This review focuses on covalent organic–inorganic hybridization as a modular strategy to engineer POMs for visible-light photoactivation. By grafting chromophoric ligands, metalloporphyrins, or organometallic complexes onto POM surfaces via robust covalent bonds (e.g., Si–C, P–C, C–C), two key photochemical pathways are enabled: (i) direct visible-light excitation of organic sensitizers followed by intramolecular charge transfer to/from POMs and (ii) modified ligand-to-metal charge transfer (LMCT) transitions in POMs via ligand-induced electronic structure perturbation. We discuss how organic ligands regulate POM frontier orbital energy levels (HOMO/LUMO), redox potentials, and photoresponse range, supported by experimental and density-functional theory (DFT) studies. We also review hybrid systems with organic photosensitizers (e.g., pyrene, boron dipyrromethene (BODIPY)), metalloporphyrins, and organometallic complexes (e.g., Ru(II), Ir(III)), emphasizing structure–activity relationships in electron-transfer efficiency, charge-separation lifetime, and catalytic performance (e.g., hydrogen evolution, selective oxidation). Finally, we outline current challenges and prospects for designing multifunctional POM hybrids with tailored visible-light photocatalytic properties. Full article

Photodynamic therapy (PDT) is a cornerstone non-invasive modality for keratinocytic precancers and non-melanoma skin cancer (NMSC), leveraging selective photosensitizer accumulation, light activation, and reactive oxygen species (ROS) generation. This narrative review synthesized literature from major databases (2010–2025) to comprehensively evaluate PDT’s molecular mechanisms, innovative optimization protocols, and clinical efficacy across actinic keratosis (AK), field cancerization, Bowen’s disease (BD), basal cell carcinoma (BCC), and invasive squamous cell carcinoma (cSCC). The evidence highlights frontline clinical maturity and excellent cosmetic outcomes for superficial lesions (AK, field cancerization, superficial BCC, and BD), with daylight PDT offering a virtually painless alternative for widespread dysplasia. However, therapeutic reliability decreases in thick nodular, pigmented, or high-risk lesions due to optical barriers and tissue hypoxia. To overcome these limitations, advanced physical and chemical enhancements—such as ablative fractional lasers, iron chelators, epigenetically enhanced PDT (ePDT), and targeted nanocarriers—are actively reshaping drug delivery and cellular susceptibility. Furthermore, cyclic PDT serves as an indispensable tissue-sparing intervention for organ transplant recipients and Gorlin syndrome patients. In conclusion, while PDT is highly effective for superficial neoplasias, precise histopathological stratification and the integration of nanomedicine are critical to overcoming current biological barriers in aggressive dermatological malignancies. Full article

Background/Objectives: An evaluation of the sensitizing properties of chloroindium(III) phthalocyanine complex (InPc) bearing 4-sulfonylphenoxy groups was performed. Methods: The ability to form singlet oxygen under light exposure was assessed, and the quantum yield Φ_Δ was calculated to be 0.82 ± 0.04. Under ultrasound exposure of the sensitizer (1 MHz, 3 W, 40% duty cycle), significant 1,3-diphenylisobenzofuran decomposition was observed. Results: Moreover, the macrocycle was assigned to be a moderate–high photo- and sonostable sensitizer. Density functional theory studies supported experimental results, suggesting the InPc to be a good photochemical agent. From the global reactivity parameters analysis, it can be suggested that InPc would interact easily with electron-excess species, such as various free radicals, in the solution phase, and should also be able to interact with electrophilic species. Conclusions: Studied InPc revealed high photodynamic antimicrobial activity and reached >4 log₁₀ reduction in microbial growth against methicillin-resistant Staphylococcus aureus, and 4.08 ± 0.29 log₁₀ against Candida albicans resistant to fluconazole (for dosimetry of 100 μM and 50 J/cm²). Interestingly, the photosensitizer studied was inactive against extended-spectrum β-lactamase-producing Escherichia coli. Full article

Dye-sensitized solar cells (DSSCs), belonging to the third generation, are highlighted for their low production cost compared to other photovoltaic technologies. These cells are composed of a cathode, an electrolyte, and an anode, commonly using TiO₂. This work aims to produce and characterize CeO₂, SnO₂, and ZrO₂ oxides as substitutes for TiO₂ in DSSCs. The semiconductor oxides were synthesized using the Pechini methodology and applied as the anode of the system. The device was assembled in a sandwich configuration, with an anode and cathode (graphene), an active area of 0.2 cm², and an electrolyte containing the I₃⁻/3I⁻ redox pair. The techniques employed included scanning electron microscopy (SEM), dynamic light scattering (DLS), X-ray diffraction (XRD), UV-Vis spectroscopy, open-circuit potential curves and electrochemical impedance spectroscopy (EIS). The oxides exhibited good crystallization with non-defined morphology. The obtained band gap values were 2.8 eV, 3.0 eV, 3.1 eV, and 4.8 eV for CeO₂, TiO₂, SnO₂, and ZrO₂, respectively. In DSSCs, these oxides showed photosensitivity, generating potential when exposed to light with TiO₂-based cell exhibited the lowest charge transfer resistance (R_ct = 57.8 kΩ). This comparative framework establishes a preliminary screening of the intrinsic interfacial charge transfer and recombination kinetics of alternative standalone photoanodes, serving as a baseline for future device optimization. Full article

The rise of antimicrobial resistance and the persistence of difficult-to-treat infections have stimulated interest in new strategies to overcome these problems. Among these strategies, dendrimers, which are highly branched monodisperse macromolecules, have emerged as innovative antimicrobial and anti-infective platforms. Dendrimers can act as intrinsic antimicrobial agents through multivalent interactions or membrane disruption or serve as nanocarriers for antibiotics, antiviral agents, antibiofilm compounds, gas-releasing active molecules, or photosensitizers. This review analyzes dendrimer-based anti-infective systems for which in vivo or clinical evaluation has been reported. The literature covers diverse platforms, including PAMAM, poly(L-lysine), peptide, carbosilane, phosphorhydrazone, polyglycerol, polyester, and other dendritic architectures. The available evidence includes infected animal models, pharmacokinetic and biodistribution studies, local tolerance studies, and clinical trials. PAMAM systems are the most extensively explored preclinically, whereas poly(L-lysine) dendrimer astodrimer/SPL7013 remains the most clinically advanced example. Overall, dendrimers provide a chemically tunable and biologically versatile approach to anti-infective research, but the current evidence remains heterogeneous. Direct comparison across studies is limited by differences in dendrimer scaffold, generation, surface chemistry, formulation, pathogen, infection model, administration route, dosing regimen, and biological endpoint. Future development will require better-defined in vivo models, more systematic safety and biodistribution studies, clearer structure–activity relationships, and stronger links between in vitro activity and clinically relevant efficacy. Full article

Photodynamic therapy (PDT) represents a highly promising modality for cancer treatment; however, its clinical success is significantly restricted by the hypoxic nature of the tumor microenvironment (TME). Hypoxia also upregulates hypoxia-inducible factor-1α (HIF-1α) expression, thereby exacerbating tumor malignancy. To tackle this challenge, we engineered a hypoxia-activatable supramolecular nanoplatform (GH@CyNPs) capable of dual hypoxia reversal and amplification of PDT efficacy. The nanoplatform was constructed via host–guest interactions between a water-soluble pillar[5]arene (WP5) and an azobenzene-linked cyanine/YC-1 conjugate (Cy-G), followed by the co-encapsulation of glucose oxidase (GOx) and catalase (CAT). Upon entering the cancer cells via endocytosis, the azobenzene linker is specifically cleaved by the hypoxic TME, facilitating payload release. Concurrently, the released GOx/CAT pair drives in situ cascade reactions to generate oxygen (O₂), while YC-1 effectively suppresses HIF-1α expression, thereby achieving synergistic alleviation of hypoxia. Under irradiation, the released cyanine acts as a potent photosensitizer, generating abundant reactive oxygen species (ROS) to kill cancer cells. Both in vitro and in vivo evaluations corroborated that GH@CyNPs exhibit preferential tumor accumulation, profound antitumor efficacy, and excellent biocompatibility. This study presents an innovative paradigm for overcoming TME hypoxia to optimize photodynamic oncotherapy. Full article

We report the synthesis and photophysical properties of a new crystalline Zn^II-based heteroleptic coordination polymer, Zn₂(trz₂An)(trz)₂, obtained from the combination of 3,6-N-ditriazolyl-2,5-dihydroxy-1,4-benzoquinone ligand (H₂trz₂An) and 1H-1,2,4-triazole (Htrz). Single-crystal X-ray diffraction reveals the formation of an extended network of Zn-triazole layers pillared by anilate ligands, resulting in an overall three-dimensional connectivity reminiscent of the heavily researched CALF-20(Zn). In contrast to CALF-20, the π-conjugated anilate pillars impart a richer electronic structure, giving rise to ligand-centered excited states and detectable luminescence. Photophysical investigations reveal that the optical response is dominated by the intrinsic photosensitivity of the anilate unit and is further modulated by metal coordination and framework formation. These findings further expand the ever-growing coordination chemistry of trz₂An²⁻ linkers and demonstrate that the combination of π-conjugated anilate ligands with N-donor co-ligands is a promising strategy for the design of light-responsive coordination frameworks and, in this case, the assembly of a new heteroleptic anilate-based coordination framework with luminescent properties. Full article

Natural product-based upconversion photosensitizers (PSs) have emerged as innovative agents in photodynamic therapy (PDT). Lanthanide ions such as Yb³⁺, Er³⁺, Nd³⁺, Gd³⁺, and Tm³⁺ have unique photophysical properties and biocompatibility, exhibiting sharp 4f–4f transitions and long-lived excited states involving the dual luminescence processes, upconversion and downshifting. Natural product photosensitizers (PSs), including coumarin, riboflavin, curcumin, chlorophyll derivatives, and hypocrellin, offer superior safety profiles compared with synthetic PSs. Recent advances in upconversion nanoparticles (UCNPs) and upconversion–downshifting nanoparticles (UDNPs) for the generation of ROS in PDT have been evaluated. This narrative review surveyed the literature published between 1995 and 2026 across multiple electronic databases, including WanFang Data, PubMed, ScienceDirect, Scopus, Web of Science, Springer Link, SciFinder, and the China National Knowledge Infrastructure (CNKI), without language restrictions. The search focused on studies related to photodynamic therapy, lanthanide photophysics, and natural product photosensitizers such as coumarin, riboflavin, curcumin, chlorophyll derivatives, and hypocrellin, as well as nanoplatforms involving upconversion (UCNPs) and upconversion–downshifting nanoparticles (UDNPs). Relevant publications were identified and synthesized to integrate advances in lanthanide photophysics, natural product PSs, and nanoplatform design into a conceptual framework. Natural product-based upconversion PSs for PDT have the advantages of low dark toxicity, biocompatibility, and multimodal actions. Lanthanide-enhanced systems overcome these issues, including shallow tissue penetration, photobleaching, and relatively low singlet oxygen quantum yields. Thus, natural product-based upconversion PSs in PDT are an innovative strategy, but bridging preclinical promise with clinical translation remains a critical future challenge. Full article

Chlorophyll, a natural photosynthetic pigment, is gaining interest for its sustainable and eco-friendly applications in renewable energy, particularly as a photosensitizer in dye-sensitized solar cells (DSSCs). This study investigates the feasibility of chlorophyll extracted from Moringa oleifera as a natural photosensitizer in DSSCs, building on our previous work demonstrating its high chlorophyll content and long-term stability. Chlorophyll was extracted using acetone under optimal conditions (45 °C, 60 min) and applied in DSSCs comprising a TiO₂ photoanode, iodide/triiodide electrolyte, and platinum counter electrode. The TiO₂ photoanode was characterised using UV-Vis spectroscopy, FE-SEM, XRD, and Raman spectroscopy, confirming the presence of pure anatase phase TiO₂ with uniform spherical nanoparticle morphology. The fabricated DSSCs achieved a short-circuit current density of 0.197 mA cm⁻², an open-circuit voltage of 0.44 V, a fill factor of 32%, and a photoconversion efficiency (PCE) of 0.027%. While this performance is lower than the highest reported chlorophyll-based DSSC efficiency (4.6%), the results demonstrate that M. oleifera is a viable and sustainable source of chlorophyll for DSSC applications. The findings highlight the importance of dye–semiconductor interactions and suggest that further optimisation through co-sensitization, TiO₂ surface modification, and improved dye anchoring could enhance device performance. Full article

Triple negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer characterized by the absence of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), resulting in limited options for targeted therapy and high rates of metastasis, recurrence and death. Extracellular vesicles (EVs) have emerged as central mediators of TNBC pathophysiology, functioning as key intercellular communication vehicles transporting oncogenic proteins, nucleic acids, lipids, and metabolites. These EV-mediated interactions promote tumor microenvironment (TME) remodeling, immune evasion, metastatic niche formation, and therapeutic resistance. Given their stability, accessibility, and molecular complexity, EVs also represent promising diagnostic and prognostic biomarkers for TNBC. Advances in isolation and molecular profiling technologies have enabled the identification of EV-associated signatures that predict therapeutic response and stratify patient risk. Beyond their utility as biomarkers, EVs are rapidly emerging as therapeutic targets and delivery platforms, demonstrating efficacy in transporting chemotherapeutics, RNA-based therapeutics, immune modulators, and photosensitizers with enhanced targeting specificity and therapeutic efficiency. Collectively, EVs play a multifaceted role in TNBC biology, serving simultaneously as drivers of disease progression, minimally invasive biomarkers, and versatile therapeutic vehicles. The integration of EV-centered diagnostics, multi-omic profiling, and engineered therapeutics holds significant potential to transform TNBC management and advance precision oncology for this challenging breast cancer subtype. Full article

This review aims to clarify the molecular design principles and operational challenges of photoinduced electron transfer (PET) and photoredox processes in metal complexes. The manuscript is structured to include a survey of established conventional systems, such as Ru complexes, followed by our own research on cost-effective photosensitizers for dye-sensitized solar cells (DSSCs) and carbon dioxide (CO₂) reduction. Crucially, our main conclusion emphasizes that achieving high optoelectronic efficiency requires the balanced optimization of excited-state lifetimes, orbital distributions, and matrix environments, rather than a simplistic “one-size-fits-all” approach. Finally, based on the fundamental principles of metal complexes and photocatalytic materials, we offer a critical analysis of the practical challenges and reasons behind our unsuccessful experimental outcomes. Thus, this study provides a perspective on unsuccessful molecular design, comparing typical examples. Full article

Donor–acceptor (D–A) molecular systems are gaining increasing attention in cancer imaging and phototherapy due to their tunable optical properties and high photosensitizing efficiency. Encapsulation of such D–A molecules in nano-sized polymeric carriers can enhance the efficiency of antitumor therapy by passive tumor accumulation and controlled drug release. Here, we synthesized two D–A molecules—TTDCV and TTInd—based on triphenylamine with thiophene π-spacers and electron-withdrawing dicyanovinyl or indene-1,3-dione moieties. These molecules were used to preparate nanoparticles (NPs) via nanoprecipitation with amphiphilic polymers—poly(ethylene glycol)-block polylactide methyl ether (PEG-b-PLA) and polyethylene oxide-polypropylene oxide (PEO-PPO-PEO, Pluronic^® F-127). The resulting NPs had spherical morphology, core–shell structure and a tunable mean size (66–139 nm), depending on the polymer type used. Photothermal and photodynamic properties of the NPs were confirmed by intracellular reactive oxygen species generation and efficient heating even under 530 nm low dose irradiation (1 J/cm²), leading to substantial in vitro cytotoxicity against Sk-Br-3 and MCF-7 human breast cancer cells. Pluronic-encapsulated systems showed the strongest effect, reducing IC₅₀ values down to 0.99 µg/mL and achieving phototoxicity indices up to 22, accompanied by increased intracellular accumulation studied by confocal microscopy and flow cytometry. This study establishes relationships between molecular design, encapsulation approaches, and the biological performance of nanoparticles, enabling the rational engineering of D–A-derived nanotherapeutics for precision cancer treatment. Full article

Semiconductor–biological hybrid systems (SBHS) have emerged as a disruptive technology for solar-driven chemical manufacturing, effectively bypassing the thermodynamic bottlenecks of natural photosynthesis. However, the aggressive pursuit of record-breaking solar-to-chemical conversion efficiencies has inadvertently fostered an efficiency trap. A profound interdisciplinary schism exists wherein the acute environmental toxicity and long-term interfacial instability of these hybrid architectures are frequently overlooked. This review provides a critical appraisal of the oft-ignored environmental risks inherent in current SBHS designs. We systematically dissect the heavy metal leaching toxicity of first-generation inorganic photosensitizers and unveil the complex, bidirectional degradation mechanisms at the abiotic–biotic interface. Specifically, we highlight the dual threats of photogenerated reactive oxygen species inducing cellular oxidative stress and active, microbially induced material dismantling via reductive dissolution driven by extracellular electron transfer. To navigate beyond this purely performance-driven paradigm, we propose a multidimensional, standardized evaluation matrix that systematically balances catalytic efficiency with biological safety and life-cycle sustainability. Ultimately, this review offers a comprehensive roadmap to transition biohybrid platforms from fragile laboratory concepts into robust, scalable, and ecologically benign negative-emission technologies. Full article

Glioblastoma remains the most aggressive primary brain malignancy, with poor survival despite maximal safe resection, radiotherapy, and temozolomide-based chemotherapy. A major obstacle to effective treatment is the spatially heterogeneous blood–brain barrier/blood–tumor barrier, which restricts drug penetration into infiltrative tumor regions and limits uniform intratumoral exposure. Albumin-based delivery is attractive in glioblastoma because it addresses several formulation-level barriers at once: poor aqueous solubility of hydrophobic payloads, short systemic exposure, and the need for a biocompatible carrier that can interact with albumin-handling pathways such as gp60/albondin, SPARC, FcRn, and caveolin-associated transport. This review examines albumin-based strategies explored for glioblastoma, with an emphasis on albumin-bound paclitaxel nanoparticles, engineered albumin nanoparticles, dual-payload systems, albumin-binding photosensitizers, macrophage-assisted delivery, and albumin-bound pathway-directed agents. Preclinical evidence suggests that these platforms can improve brain-tumor drug exposure, support rational combinations, and synergize with BBB/BTB-opening technologies. Early clinical studies combining low-intensity pulsed ultrasound with microbubbles and albumin-bound paclitaxel provide human proof of concept for regional pharmacokinetic enhancement in recurrent glioblastoma, although survival benefit remains unproven. The available evidence supports albumin-based delivery as a rational formulation strategy. Its clinical value in GBM will depend on three testable requirements: spatial pharmacokinetic confirmation, biomarker-guided patient selection, and reproducible BBB/BTB modulation. Full article

As semiconductor packaging technology evolves from two-dimensional to three-dimensional integration, the through-glass via (TGV) technique, as a core interconnect method in advanced packaging, is emerging as a strong candidate to replace through-silicon vias (TSVs) and plated through-holes (PTHs) in organic substrates. Glass substrates offer excellent electrical insulation, low dielectric loss, tunable thermal expansion coefficients, and the potential for large-scale panel-level manufacturing. However, issues related to TGV hole quality, metallization uniformity, and thermomechanical reliability remain key bottlenecks limiting their large-scale industrialization. This investigation provides a comparative review of non-laser and laser machining for TGVs to address the above problems. First, the technical background and core advantages of TGVs are outlined. Second, this study details non-laser processing methods, including sandblasting erosion, mechanical drilling, the photosensitive glass method, electrochemical discharge machining (ECDM), deep reactive ion etching (DRIE), and others. Third, laser processing methods, covering laser ablation drilling, laser-induced deep etching (LIDE), femtosecond laser-assisted wet etching and others, are given focus. Moreover, this study analyzes typical applications of TGVs in 3D/2.5D packaging, MEMS devices, optoelectronic integration, and others. In addition, the machining processes of non-laser and laser-based TGVs, such as mechanical machining, ECDM, and LIDE, are compared, and key process challenges, technical trade-offs, and reliability failure mechanisms are discussed. Finally, this review looks ahead to future trends, aiming to provide a systematic technical reference for researchers in the TGV field. Full article